CG
MDGL icon

Cutler Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Cutler Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.09M Sell
36,900
-19,300
-34% -$4.55M 0.36% 65
2023
Q4 		$746K Sell
56,200
-27,300
-33% -$4.78M 0.07% 316
2023
Q3 		$248K Buy
83,500
+38,700
+86% +$7.28M 0.03% 673
2023
Q2 		$511K Sell
44,800
-13,400
-23% -$3.63M 0.07% 318
2023
Q1 		$4.16M Buy
58,200
+1,300
+2% +$354K 0.43% 44
2022
Q4 		$7.17M Buy
+56,900
New +$5.56M 0.61% 26
2022
Q3 		– Sell
-4,500
Closed -$4K – 5271
2022
Q2 		$4K Buy
4,500
+4,000
+800% +$294K ﹤0.01% 3880
2022
Q1 		$3K Sell
500
-100
-17% -$8.43K ﹤0.01% 4481
2021
Q4 		$5K Sell
600
-500
-45% -$41.1K ﹤0.01% 4202
2021
Q3 		$7K Buy
1,100
+900
+450% +$77.7K ﹤0.01% 4222
2021
Q2 		$1K Sell
200
-900
-82% -$107K ﹤0.01% 5346
2021
Q1 		$9K Sell
1,100
-500
-31% -$58.3K ﹤0.01% 3891
2020
Q4 		$11K Buy
1,600
+600
+60% +$73.3K ﹤0.01% 3129
2020
Q3 		$1K Sell
1,000
-1,800
-64% -$195K ﹤0.01% 4386
2020
Q2 		$42K Buy
+2,800
New +$275K ﹤0.01% 1861
2019
Q3 		– Sell
-7,100
Closed -$31K – 4444
2019
Q2 		$31K Sell
7,100
-6,900
-49% -$739K ﹤0.01% 1891
2019
Q1 		$21K Sell
14,000
-4,600
-25% -$572K ﹤0.01% 2020
2018
Q4 		$45K Buy
18,600
+4,400
+31% +$681K ﹤0.01% 1547
2018
Q3 		$31K Buy
14,200
+8,900
+168% +$2.23M ﹤0.01% 1941
2018
Q2 		$45K Buy
+5,300
New +$931K ﹤0.01% 1672

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cutler Group's MDGL Position: Q1 2024 in Review

Cutler Group increased its Madrigal Pharmaceuticals (MDGL) stake by 17% in Q1 2024, buying an estimated $542K and bringing the position to 15,800 shares worth $4.22M. The position accounts for 1.37% of the portfolio, ranked #6.

Cutler Group first reported a position in MDGL in Q4 2015 and has held it in 28 quarters since. 268 funds tracked by Wall St. Rank hold MDGL as of Q1 2024.

  • Cutler Group held 15,800 shares of Madrigal Pharmaceuticals worth $4.22M as of Q1 2024.
  • Cutler Group bought 2,300 Madrigal Pharmaceuticals shares in Q1 2024, an estimated $542K.
  • Madrigal Pharmaceuticals made up 1.37% of Cutler Group's portfolio in Q1 2024, its #6 holding.
  • Cutler Group first reported a position in Madrigal Pharmaceuticals in Q4 2015 and has held it in 28 quarters since.
  • 268 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.